Literature DB >> 6676695

The morphology and morphogenesis of jaagsiekte retrovirus (JSRV).

A L Payne, D W Verwoerd, H M Garnett.   

Abstract

Jaagsiekte retrovirus ( JSRV ) was recently shown to be the aetiological agent of jaasiekte (ovine pulmonary adenomatosis). The morphogenesis of JSRV was studied in jaagsiekte tumour tissue. Intracytoplasmic particles, often associated with centrioles, were found in tumour cells. JSRV budded from tumour cells with a complete core which appeared to mature during the budding process. Extracellular particles were found in the alveolar lumen. Immature extracellular particles were rare. Mature extracellular JSRV was membrane-bound and had a slightly eccentric nucleoid with an electron-dense perinucleoidal space. In negatively stained preparations of JSRV the envelope was covered with spikes. JSRV is morphologically distinct from all known retroviruses.

Entities:  

Mesh:

Year:  1983        PMID: 6676695

Source DB:  PubMed          Journal:  Onderstepoort J Vet Res        ISSN: 0030-2465            Impact factor:   1.792


  4 in total

1.  Novel endogenous type D retroviral particles expressed at high levels in a SCID mouse thymic lymphoma.

Authors:  S Ristevski; D F Purcell; J Marshall; D Campagna; S Nouri; S P Fenton; D A McPhee; G Kannourakis
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

2.  Nucleotide sequence of the jaagsiekte retrovirus, an exogenous and endogenous type D and B retrovirus of sheep and goats.

Authors:  D F York; R Vigne; D W Verwoerd; G Querat
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

3.  Isolation, identification, and partial cDNA cloning of genomic RNA of jaagsiekte retrovirus, the etiological agent of sheep pulmonary adenomatosis.

Authors:  D F York; R Vigne; D W Verwoerd; G Querat
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

4.  Pericentriolar Targeting of the Mouse Mammary Tumor Virus GAG Protein.

Authors:  Guangzhi Zhang; David Sharon; Juan Jovel; Lei Liu; Eytan Wine; Nasser Tahbaz; Stanislav Indik; Andrew Mason
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.